502 South Magnolia Avenue Corporation is categorized under Internal Medicine Doctors in Orlando, FL and active since 2001.
502 South Magnolia Avenue Corporation was established in 2001, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Internal Medicine Doctors business, which does work in the B2C market, and is classified as a Internal Medicine Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact James S Pendergraftm Iv at the company’s single location by writing to 1103 Lucerne Terrace, Orlando, Florida FL 32806 or by phoning (407) 245-7999. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | 502 South Magnolia Avenue Corporation |
Contact Person: | James S Pendergraftm Iv |
Address: | 1103 Lucerne Terrace, Orlando, Florida 32806 |
Phone Number: | (407) 245-7999 |
Annual Revenue (USD): | $100.000 to $499.999 |
Founded: | 2001 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Internal Medicine Doctors |
SIC Code: | 8011 |
NAICS Code: | 621111 |
Share This Business: |
502 South Magnolia Avenue Corporation was started in 2001 to provide professional Internal Medicine Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact James S Pendergraftm Iv for inquiries that concern 502 South Magnolia Avenue Corporation by calling the company number (407) 245-7999, as your correspondence is most welcome. Additionally, the physical location of the single location of 502 South Magnolia Avenue Corporation can be found at the coordinates 28.52813,-81.380546 as well as the street address 1103 Lucerne Terrace in Orlando, Florida 32806.
For its online presence, you may visit 502 South Magnolia Avenue Corporation’s website at and engage with its social media outlets through on Twitter and on Facebook.